Reported Reactions

Devices › Implant, endosseous, orthodontic

Device brand name · Endosseous dental implant

Palatal Implant ?4.1, L 4.2mm: medical device reports filed with FDA

333 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code OAT.

333
device reports naming the brand
0% of all MAUDE reports · about 49 a year
19
reports, 12 months to August 2026
42 in the 12 months before
0%
classified as malfunction
3.5% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

333 medical device reports received by FDA name the brand "Palatal Implant ?4.1, L 4.2mm" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to July 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

19 reports arrived in the 12 months to August 2026, down 55% from 42 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, orthodontic reports (product code OAT) death is recorded in 0% and malfunction in 3.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (92.5%), loss of osseointegration (5.1%) and output problem (0.3%). The patient problems coded most often are fibrosis, tissue damage and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0917Sep 2021: 5Oct 2021: 2Nov 2021: 6Dec 2021: 32022Jan 2022: 4Feb 2022: 5Mar 2022: 3Apr 2022: 7May 2022: 4Jun 2022: 5Jul 2022: 17Aug 2022: 8Sep 2022: 2Oct 2022: 3Nov 2022: 4Dec 2022: 52023Jan 2023: 6Feb 2023: 4Mar 2023: 8Apr 2023: 9May 2023: 3Jun 2023: 4Jul 2023: 1Aug 2023: 2Sep 2023: 5Oct 2023: 3Nov 2023: 4Dec 2023: 22024Jan 2024: 1Feb 2024: 2Mar 2024: 3Apr 2024: 6May 2024: 3Jun 2024: 5Jul 2024: 1Aug 2024: 0Sep 2024: 0Oct 2024: 11Nov 2024: 5Dec 2024: 32025Jan 2025: 3Feb 2025: 6Mar 2025: 0Apr 2025: 1May 2025: 0Jun 2025: 6Jul 2025: 7Aug 2025: 0Sep 2025: 0Oct 2025: 1Nov 2025: 3Dec 2025: 22026Jan 2026: 2Feb 2026: 0Mar 2026: 3Apr 2026: 4May 2026: 0Jun 2026: 2Jul 2026: 2Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

034672019: 2720192020: 4920202021: 5720212022: 6720222023: 5120232024: 4020242025: 2920252026: 132026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%333
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%333
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 430 reports carrying product code OAT. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate30892.5%77.4%
Loss of osseointegration175.1%3.5%
Output problem10.3%0%
Unintended movement10.3%4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis12136.3%
Tissue damage5516.5%
Painpain, site not specified247.2%
Inflammationinflammation133.9%
Swelling/ edema103%
Hemorrhage/blood loss/bleeding82.4%
Failure of implant41.2%
Hyperresponsive to stimuli30.9%
Inadequate osseointegration30.9%
Hypersensitivity/allergic reaction20.6%
Fistula10.3%
Swellingswelling10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasurePalatal Implant ?4.1, L 4.2mmProduct code OATAll MAUDE reports
Reports33343026,136,888
Share of that pool—77.4%0%
Classified as death, per 1,000 reports009
Classified as injury100%96.3%36.2%
Classified as malfunction0%3.5%62.3%
Filed by the manufacturer100%98.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Questions about Palatal Implant ?4.1, L 4.2mm reports

How many FDA reports name Palatal Implant ?4.1, L 4.2mm?

333 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 19 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (92.5%), loss of osseointegration (5.1%), output problem (0.3%) and unintended movement (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Palatal Implant ?4.1, L 4.2mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.